American Diabetes Association
Browse

Phenotypic vs. Genetic Mismatch of BMI and Type 2 Diabetes: Evidence from Two Perspective Cohort Studies

Download (911.12 kB)
figure
posted on 2024-12-10, 18:42 authored by Aolin Li, Shuo Gong, Canqing Yu, Pei Pei, Ling Yang, Iona Y. Millwood, Robin G. Walters, Yiping Chen, Huaidong Du, Xiaoming Yang, Wei Hou, Junshi Chen, Zhengming Chen, Jun Lv, Liming Li, Dianjianyi Sun, China Kadoorie Biobank Collaborative Group

Little is known about the population-based mismatch between phenotypic and genetic BMI (BMI-PGM) and its association with type 2 diabetes. We therefore used data from the China Kadoorie Biobank and UK Biobank and calculated BMI-PGM for each participant as the difference between the percentile for adjusted BMI at baseline and the percentile for adjusted polygenic risk score for BMI. Participants were categorized into discordantly low (BMI-PGM< the 1st quartile), concordant (the 1st quartile ≤BMI-PGMrd quartile), and discordantly high (BMI-PGM≥the 3rd quartile) groups. We calculated adjusted hazard ratios (aHRs) for the association of BMI-PGM and type 2 diabetes using Cox proportional hazard models in each cohort, and combined HRs using random-effects meta-analyses. During a median follow-up of 12 years for both cohorts, BMI-PGM was associated with the risk of type 2 diabetes, with the discordantly low group showing reduced risk and the discordantly high group showing elevated risk compared to the concordant group, independent of BMI and other conventional risk factors. In addition, normal-weight individuals with discordantly high BMI-PGM faced a higher risk of type 2 diabetes than overweight individuals.These findings suggest that BMI-PGM may play a potential role in reassessing the risk of type 2 diabetes, particularly among normal-weight populations.

Funding

This work was supported by the National Key R&D Program of China (2023YFC2509400) and the National Natural Science Foundation of China (82103920, 82388102, 82192901, 82192904, 82192900). The CKB baseline survey and the first re-survey were supported by the Kadoorie Charitable Foundation in Hong Kong. The long-term follow-up has been supported by Wellcome grants to Oxford University (212946/Z/18/Z, 202922/Z/16/Z, 104085/Z/14/Z, 088158/Z/09/Z) and grants (2016YFC0900500) from the National Key R&D Program of China, National Natural Science Foundation of China (82388102, 81390540, 91846303, 81941018), and Chinese Ministry of Science and Technology (2011BAI09B01). The UK Medical Research Council (MC_UU_00017/1, MC_UU_12026/2, MC_U137686851), Cancer Research UK (C16077/A29186, C500/A16896) and the British Heart Foundation (CH/1996001/9454), provide core funding to the Clinical Trial Service Unit and Epidemiological Studies Unit at Oxford University for the project.

History

Usage metrics

    Diabetes

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC